{"organizations": [], "uuid": "e0b63ffa92b60a872eb9bac0de49fac7baa1d90f", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-atara-biotherapeutics-reports-q1-l/brief-atara-biotherapeutics-reports-q1-loss-per-share-1-05-idUSASC0A0F4", "country": "US", "domain_rank": 408, "title": "BRIEF-Atara Biotherapeutics Reports Q1 Loss Per Share $1.05", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-05-08T14:54:00.000+03:00", "replies_count": 0, "uuid": "e0b63ffa92b60a872eb9bac0de49fac7baa1d90f"}, "author": "", "url": "https://www.reuters.com/article/brief-atara-biotherapeutics-reports-q1-l/brief-atara-biotherapeutics-reports-q1-loss-per-share-1-05-idUSASC0A0F4", "ord_in_thread": 0, "title": "BRIEF-Atara Biotherapeutics Reports Q1 Loss Per Share $1.05", "locations": [], "entities": {"persons": [], "locations": [{"name": "atara", "sentiment": "none"}], "organizations": [{"name": "brief-atara biotherapeutics", "sentiment": "negative"}, {"name": "atara biotherapeutics inc", "sentiment": "none"}, {"name": "reuters staff", "sentiment": "none"}, {"name": "atara biotherapeutics inc", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "thomson reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "May 8, 2018 / 11:55 AM / Updated 8 minutes ago BRIEF-Atara Biotherapeutics Reports Q1 Loss Per Share $1.05 Reuters Staff\nMay 8 (Reuters) - Atara Biotherapeutics Inc:\n* ATARA BIOTHERAPEUTICS ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS AND RECENT OPERATIONAL PROGRESS * ATARA BIOTHERAPEUTICS INC Q1 SHR LOSS $1.05\n* ATARA BIOTHERAPEUTICS INC Q1 SHR VIEW $-0.92 â€” THOMSON REUTERS I/B/E/S\n* ATARA BIOTHERAPEUTICS INC - CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS AS OF MARCH 31, 2018 TOTALED $407.3 MLN Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-05-08T14:54:00.000+03:00", "crawled": "2018-05-08T15:17:56.004+03:00", "highlightTitle": ""}